Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003562317 | SCV004293847 | likely pathogenic | not provided | 2023-12-01 | criteria provided, single submitter | clinical testing | This sequence change falls in intron 3 of the NPHS2 gene. It does not directly change the encoded amino acid sequence of the NPHS2 protein. RNA analysis indicates that this variant induces altered splicing and may result in an absent or disrupted protein product. This variant is not present in population databases (gnomAD no frequency). This variant has been observed in individuals with steroid-resistant nephrotic syndrome (PMID: 23242530, 23515051, 24969201, 30260545). Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Studies have shown that this variant results in skipping of exon 3 and introduces a premature termination codon (PMID: 24969201). The resulting mRNA is expected to undergo nonsense-mediated decay. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. |
Baylor Genetics | RCV004574090 | SCV005053686 | pathogenic | Nephrotic syndrome, type 2 | 2023-12-15 | criteria provided, single submitter | clinical testing |